Keywords: janssen-cilag, initiate, clinical, trial, first-episode, long-term, determine
Janssen-Cilag To Initiate Clinical Trial In First-Episode
Article | 25 November 1996
- Janssen-Cilag is to initiate a long-term clinical trial to determine whether early treatment in first-episode schizophrenia prevents a decline in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
